You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -326.3% | -122.9% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 40.5 | 17.4 |
| Price / Book value | 21.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 228.2% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 5.51 | -18.05 | -12.98p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 2.14 | -18.86 | -7.27p | -15.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 2.94 | -29.19 | -10.57p | -12.0 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 9.65 | -41.46 | -15.48p | -7.4 | 0.0 | n/a | n/a | 0.0% |
| Avacta reports higher losses in first half Sharecast News | 28 Sep |
|---|---|
| Avacta brings in clinical consultant as it hunts for permanent CMO Sharecast News | 20 Sep |
| Avacta upbeat on fresh data from chemotherapy trial Sharecast News | 19 Sep |
| Block Listing Six Monthly Return | 27-Oct-23 07:00 |
|---|---|
| Issue of Equity and Total Voting Rights | 23-Oct-23 13:32 |
| Block Listing Application to AIM | 18-Oct-23 13:12 |
| Avacta to present at AACR-NCI-EORTC conference | 05-Oct-23 23:59 |
| Interim Results for the Period Ending 30 June 2023 | 29-Sep-23 09:22 |